Dosidal · Switzerland

Eylea, Injektionslösung zur Intravitrealen Anwendung in einer Fertigspritze

Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.

MarketSwitzerland
Recordch:authorisation:62393 (version 1)
Levelauthorisation
Pack codenot anchored
Identifiersswissmedic-authorisation: 62393
atc: S01LA05
Source authoritySwissmedic
Read date
authorisation statusfirst_authorisation: 2012-10-29
term: zugelassen
valid_until: 9999-12-31
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
identityatc: S01LA05
authorisation_number: 62393
form: LSINJ
holder: Bayer (Schweiz) AG
holder_partner_nr: 1000372
it_number: 11.99.0.
name: Eylea, Injektionslösung zur Intravitrealen Anwendung in einer Fertigspritze
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
SignatureES256 over JCS, key dosidal-record-1.9dbf5d53
acLxUzxtVFnkwPZ4_JWjE3eyrKiRCz8hdCACoPT-PP2fq-pG9gFnOLw63om7WXJc9oKr2CoLCzdOyh8i2b6dfg
Verify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json

JSON: https://dosidal-api.ai/v1/records/ch:authorisation:62393 · Related records in other markets · Dosidal